EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 121 filers reported holding EPIZYME INC in Q1 2022. The put-call ratio across all filers is 4.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,368,000 | +154.3% | 930,718 | +98.9% | 0.20% | +184.7% |
Q1 2022 | $538,000 | +73.0% | 467,836 | +275.8% | 0.07% | +84.6% |
Q4 2021 | $311,000 | -15.3% | 124,500 | +73.8% | 0.04% | +5.4% |
Q3 2021 | $367,000 | -34.3% | 71,652 | +11.7% | 0.04% | -60.2% |
Q1 2021 | $559,000 | -41.1% | 64,143 | -19.4% | 0.09% | -41.1% |
Q3 2020 | $949,000 | +209.1% | 79,582 | +221.6% | 0.16% | +409.7% |
Q1 2019 | $307,000 | +16.7% | 24,742 | -42.1% | 0.03% | +3.3% |
Q4 2018 | $263,000 | -30.2% | 42,766 | +94.4% | 0.03% | +50.0% |
Q1 2017 | $377,000 | -1.3% | 22,000 | -43.4% | 0.02% | -4.8% |
Q3 2016 | $382,000 | – | 38,860 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |